Establishment of Synergistic Chemoimmunotherapy for Head and Neck Cancer Using Peritumoral Immature Dendritic Cell Injections and Low-Dose Chemotherapies

The lack of available tumor antigens with strong immunogenicity, human leukocyte antigen restriction, and immunosuppression via regulatory T-cells (Tregs) and myeloid-derived suppressor cells are limitations for dendritic cell (DC)–based immunotherapy in patients with advanced head and neck cancer (...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishii, Hiroki, Chikamatsu, Kazuaki, Igarashi, Satoshi, Takahashi, Hideyuki, Sakamoto, Kaname, Higuchi, Hiroji, Tanaka, Shota, Matsuoka, Tomokazu, Masuyama, Keisuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2017
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738236/
https://www.ncbi.nlm.nih.gov/pubmed/29268186
http://dx.doi.org/10.1016/j.tranon.2017.11.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738236/
https://www.ncbi.nlm.nih.gov/pubmed/29268186
http://dx.doi.org/10.1016/j.tranon.2017.11.006

Ejemplares similares